To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Global distribution of Xpert CT/NG assay Neisseria gonorrhoeae escape variants indicates sporadic emergence with limited clonality between 2016 and 2025
Örebro University, School of Medical Sciences. WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for STIs, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.ORCID iD: 0000-0002-0688-2521
Molecular Biology, Microbiology and Serology Laboratory, Federal University of Santa Catarina, Florianópolis, Brazil.
Department of HIV/AIDS, Tuberculosis, Viral Hepatitis, and Sexually Transmitted Infection, Secretariat of Health Surveillance and Environment, Ministry of Health of Brazil, Brasília, Brazil.
Örebro University, School of Medical Sciences. Örebro University Hospital. Institute for Global Health, University College London (UCL), London, United Kingdom; WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for STIs, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.ORCID iD: 0000-0003-1710-2081
2025 (English)In: Eurosurveillance, ISSN 1025-496X, E-ISSN 1560-7917, Vol. 30, no 46, article id 2500817Article in journal (Refereed) Published
Abstract [en]

Screening of 54,837 gonococcal genomes identified 12 new variants lacking one (n = 9) or both (n = 3) of the Xpert CT/NG assay's gonococcal targets. In total, 17 diagnostic-escape variants occurred across five countries and multiple genomic lineages; phylogenomic analysis revealed both ancestral and strain-specific recombination events. Xpert CT/NG diagnostic escape remains rare (0.026%) but illustrates recurrent recombination in gonococci. This emphasises the necessity of continuous external quality assessments, supplementary testing of gonococcal-positive molecular screening samples, and appropriate genomic and epidemiologic surveillance.

Place, publisher, year, edition, pages
European Centre for Disease Prevention and Control , 2025. Vol. 30, no 46, article id 2500817
Keywords [en]
GeneXpert, Neisseria gonorrhoeae, Xpert CT/NG, antimicrobial resistance, diagnostic-escape variant, gonorrhoea, multidrug-resistant N. gonorrhoeae (MDR-GC), travel
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:oru:diva-125159DOI: 10.2807/1560-7917.ES.2025.30.46.2500817PubMedID: 41267658OAI: oai:DiVA.org:oru-125159DiVA, id: diva2:2016746
Funder
Region Örebro County
Note

Funding Agencies:

This study was supported by the Örebro County Council Research Committee and the Foundation for Medical Research at Örebro University Hospital, Örebro, Sweden.

Available from: 2025-11-26 Created: 2025-11-26 Last updated: 2025-12-30Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Golparian, DanielUnemo, Magnus

Search in DiVA

By author/editor
Golparian, DanielUnemo, Magnus
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Eurosurveillance
Infectious Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 39 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf